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Histone deacetylases (HDACs) are key regulators of gene expres-
sion that require assembly into larger protein complexes for
activity. Efforts to understand how associated proteins modulate
the function of HDACs would beneﬁt from new technologies that
evaluate HDAC activity in native biological systems. Here, we
describe an active site-directed chemical probe for proﬁling HDACs
in native proteomes and live cells. This probe, designated SAHA-
BPyne, contains structural elements of the general HDAC inhibitor
suberoylanilide hydroxamic acid (SAHA), as well as benzophenone
and alkyne moieties to effect covalent modiﬁcation and enrich-
ment of HDACs, respectively. Both class I and II HDACs were
identiﬁed as speciﬁc targets of SAHA-BPyne in proteomes. Inter-
estingly, multiple HDAC-associated proteins were also enriched by
SAHA-BPyne,evenafterdenaturationofprobe-labeledproteomes.
These data indicate that certain HDAC-associated proteins are
directly modiﬁed by SAHA-BPyne, placing them in close proximity
to HDAC active sites where they would be primed to regulate
substrate recognition and activity. We further show that SAHA-
BPyne can be used to measure differences in HDAC content and
complex assembly in human disease models. This chemical pro-
teomics probe should thus prove valuable for proﬁling both the
activity state of HDACs and the binding proteins that regulate their
function.
cancer
T
he reversible acetylation of lysine residues in histone tails
plays a critical role in transcriptional activation and repres-
sion (1, 2). Acetylation and deacetylation are catalyzed by
histone acetyltransferases (HATs) and histone deacetylases
(HDACs), respectively. Increased HDAC activity has generally
been associated with transcriptional repression, whereas in-
creased HAT activity (or HDAC inhibition) facilitates gene
expression (1, 2). There are 20 human HDACs that fall into
three classes based on homology to yeast models; classes I and
II are zinc-dependent metallohydrolases (3), whereas class III
HDACs are NAD-dependent deacetylases (4). Treatment of
tumor cells with general inhibitors of class I/II HDACs results in
growth arrest, differentiation, and apoptosis (1–6), promoting
these enzymes as potential cancer drug targets (7).
Most HDACs are found in cells as parts of large multisubunit
complexes such as the nucleosome remodeling and deacetylating
(NURD), CoREST, and mSin3 complexes (8–10). Participation
in these complexes appears to be required for HDAC activity, as
isolatedenzymesarenotgenerallycapableofefficientlydeacety-
latinglysines(11).ThespecificcomponentsofHDACcomplexes
influence substrate selection and, consequently, HDAC-
mediated gene regulation (12, 13). Despite the importance of
protein–protein interactions for HDAC activity, little is known
about how this regulatory effect is exerted at a molecular level.
Such studies are complicated by the difficulties in reconstituting
HDAC activity in purified, recombinant systems (14). New
methods are thus needed to monitor the functional state of
HDAC complexes in native biological systems. We set out to
address this problem by developing an active-site-directed chem-
ical probe for profiling HDAC activities in proteomes.
Results
Design of an Activity-Based Proteomic Probe for Class I/II HDACs. An
HDAC-directed probe was designed based on the scaffold of the
general class I/II HDAC inhibitor suberoylanilide hydroxamic acid
(SAHA)(3)(1,Fig.1A).SAHAisareversibleHDACinhibitorthat
chelates to the Zn2 cation in HDAC active sites (15) to provide
high nM-low M inhibition (16). To convert SAHA into an
irreversible probe compatible with activity-based protein profiling
[ABPP (17, 18)] experiments, we modified the inhibitor’s structure
to include a benzophenone (BP), which can be photoactivated to
promote covalent labeling of proximal proteins. A phenyl azide
photoaffinity derivative of SAHA has been reported (19), but this
reagent was only synthesized in tritiated form, which requires long
exposure times for the detection of cross-linked proteins and does
not offer a handle for their enrichment and identification. To
addresstheseproblems,wealsoappendedanalkynegroupontoour
HDAC-directed probe to facilitate click chemistry-mediated con-
jugation of reporter tags for the rapid and sensitive detection
(rhodamine) and affinity enrichment (biotin) of labeled proteins
(20, 21). The resulting HDAC-directed probe, prepared in three
steps from commercially available materials, was termed SAHA-
BPyne (Fig. 1).
Analysis of the Proteome-Wide Reactivity Profiles of SAHA-BPyne.
Given that mammalian HDAC enzymes are not, in general,
active as purified, recombinant proteins (11, 14), initial screens
with SAHA-BPyne were performed in native cell proteomes.
SAHA-BPyne (100 nM) was added either alone, or in the
presence of excess SAHA (10 M), to soluble proteomes
prepared from the aggressive and nonaggressive human mela-
noma cell lines MUM2B and MUM2C, respectively. Samples
were then photoactivated with UV light, treated with rhodam-
ine-azide under click chemistry conditions (20, 21), and analyzed
by SDS/PAGE coupled with in-gel fluorescence scanning. Mul-
tiple SAHA-competed targets of SAHA-BPyne were detected in
cancer cell proteomes, including proteins in the predicted mo-
lecular mass range of HDACs (50–60 kDa), as well as an
additional protein of lower mass (38 kDa) (Fig. 2A). Similar
profiles were generated with cancer lines from other tissues of
origin, including breast and ovary [supporting information (SI)
Fig. 6]. The signal intensity for each probe-labeled protein was
enrichedinnuclearpreparationsfromcancercells(SIFig.7)and
also competed by a second HDAC inhibitor trichostatin A
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geted functional HDAC complexes.
To more comprehensively inventory the specific targets of
SAHA-BPyne, we reacted probe-treated cancer cell proteomes
with an azide-biotin tag and analyzed the samples using a liquid
chromatography-mass spectrometry (LC-MS) platform termed
ABPP-multidimensional protein identification technology (ABPP-
MudPIT) (22, 23). In ABPP-MudPIT, probe-labeled proteins are
enriched by binding to avidin-conjugated beads, subjected to on-
bead trypsin digestion, and identified by multidimensional LC
separation and MS–MS analysis. ABPP-MudPIT exhibits superior
resolution and sensitivity compared with gel-based methods, facil-
itating the identification of lower-abundance targets of chemical
probes in proteomes (22, 23). Multiple control samples were also
analyzed, including proteomes treated with SAHA-BPyne in the
presence of excess SAHA competitor, proteomes treated with a set
of structurally distinct hydroxamate probes that target metal-
loproteases (MPs) (23), and proteomes to which no probe was
added. Specific targets of SAHA-BPyne were identified by filtering
the data for proteins that had: (i) an average of at least four spectral
counts in SAHA-BPyne-treated samples, and (ii)a tl e a s ta2 - f o l d
increase in average spectral counts in SAHA-BPyne-treated versus
control samples. Proteins were classified as specific targets if they
met these criteria and were significantly enriched (P  0.01) in
SAHA-BPyne-treated proteomes relative to control reactions.
Multiple HDAC enzymes were identified as specific targets of
SAHA-BPyne, including HDAC1, HDAC2, and HDAC6 (Table
1). Interestingly, several additional non-HDAC proteins were
also enriched in SAHA-BPyne-treated proteomes relative to
control samples, including CoREST, p66, methyl CpG binding
protein 3 (MBD3), and the metastasis-associated proteins
MTA1 and MTA2. Literature searches revealed that these
proteins all represent components of endogenous HDAC com-
plexes (8–10). Western blotting confirmed the enrichment of
representative HDAC (HDAC2) and HDAC-associated pro-
teins(MTA2andCoREST)inSAHA-BPyne-labeledproteomes
compared with control samples (Fig. 2B).
Considering that probe-treated proteomes are subjected to
harsh protein-denaturing conditions during the ABPP-MudPIT
protocol, including exposure to boiling 0.2% SDS and 6 M urea,
these results indicated that SAHA-BPyne was capable of co-
valently labeling not only HDACs, but also HDAC-associated
proteins. To provide further evidence that SAHA-BPyne co-
valently modified HDAC-associated proteins, we pursued the
identification of the 38-kDa target of this probe (originally
detected by gel-based ABPP, Fig. 2A), as this protein’s molec-
ular mass was distinct from any of the HDACs observed by
ABPP-MudPIT. This protein was enriched by avidin chroma-
tography, separated by SDS/PAGE, subjected to in-gel trypsin
digestion, and analyzed by LC-MS/MS, resulting in its identifi-
cation as the HDAC-associated protein MBD3. By this same
Fig. 1. Design and synthesis of the HDAC activity-based probe SAHA-BPyne. (A) Structures of the general HDAC inhibitor SAHA and SAHA-BPyne. (B) Synthetic
scheme for preparation of SAHA-BPyne.
Fig. 2. ABPP of melanoma cell proteomes with the SAHA-BPyne probe. (A)
Soluble proteomes from the melanoma lines MUM2B and MUM2C were
incubated with 100 nM SAHA-BPyne probe in the presence or absence of
excess SAHA (10 M) as a competitor. Probe targets were detected by UV-
irradiation,followedbyclickchemistrywitharhodamine-azidetag,SDS/PAGE
analysis, and in-gel ﬂuorescence scanning (ﬂuorescent gel shown in gray-
scale).MultipleSAHA-sensitivetargetsweredetected(arrows).Theseproteins
were identiﬁed as HDACs 1 and 2 (60-kDa doublet) and MBD3 (38-kDa band).
(B) Conﬁrmation that SAHA-BPyne targets both HDACs (HDAC2) and HDAC-
associated (CoREST, MTA2) proteins. Shown are Western blots of proteins
enriched from melanoma proteomes by treatment with SAHA-BPyne (or
SAHA-BPyne plus excess SAHA), click conjugation to biotin-azide, and enrich-
ment on avidin beads.
1172  www.pnas.orgcgidoi10.1073pnas.0608659104 Salisbury and Cravattmethod, the SAHA-BPyne targets at 60 kDa were identified as
HDACs 1 and 2 (Fig. 2A).
Comparative Analysis of Cancer Cell Proteomes with SAHA-BPyne.
Most of the protein targets of SAHA-BPyne identified by ABPP-
MudPIT were found at similar levels in aggressive (MUM2B) and
nonaggressive(MUM2C)melanomacells(Table1).Nodifferences
were observed between the two cell lines for HDACs1 and 2, or the
associated proteins MBD3, MTA1, MTA2, and p66 (Table 1 and
SI Tables 2 and 3). In contrast, both HDAC6 and CoREST were
significantly altered, being elevated in MUM2C and MUM2B cells,
respectively (Fig. 3A). Western blotting confirmed the elevated
expression of HDAC6 in MUM2C cells (Fig. 3B). In contrast,
equivalent levels of CoREST were observed in soluble proteomes
of MUM2B and MUM2C (Fig. 3B), suggesting that the different
levels of this protein observed by ABPP-MudPIT may reflect an
alteration in HDAC complexes from these cells. Consistent with
this premise, Western blotting identified 2- to 3-fold greater
CoREST signals in avidin-enriched samples from SAHA-BPyne-
treated MUM2B versus MUM2C proteomes (Fig. 3C). These
results indicate that ABPP experiments using SAHA-BPyne can
accurately measure differences in both HDAC content and com-
plex assembly in native proteomes.
To further investigate HDAC complexes in cancer, we ana-
lyzed the SAHA-BPyne labeling profiles of the ovarian cancer
lines SKOV3 and OVCAR3 by ABPP-MUDPIT. Similar levels
of HDACs 1 and 2 were observed in ovarian lines compared with
melanoma lines; in contrast, the levels of MBD3 were markedly
lower (3- to 4-fold) in the former lines (SI Tables 2–4). Addi-
tionally, although OVCAR3 and SKOV3 shared the high
HDAC6/low CoREST signature of MUM2C cells, they were
distinguishable by higher HDAC3 signals (2- to 3-fold). These
results indicate that there is diversity in both HDACs and their
associated proteins in different forms of cancer.
Profiling HDAC Complexes in Living Cells with SAHA-BPyne. HDAC
complexes are likely regulated by many posttranslational mecha-
nisms in vivo (2), only a subset of which may be preserved in cell
extracts. We therefore tested whether SAHA-BPyne could profile
the composition and activity state of HDAC complexes in living
cells. SAHA-BPyne (500 nM) was added either alone, or in the
presence of excess SAHA (10 M), to cultured preparations of the
human breast cancer line MDA-MB-231. The cells were then
irradiated with UV light, washed (to remove excess probe), and
homogenized. Treatment of the whole cell lysates with rhodamine-
azide under click chemistry conditions and analysis by SDS/PAGE
coupled with in-gel fluorescence scanning revealed SAHA-
sensitive targets similar to those observed in the corresponding in
vitro proteomic analysis (Fig. 4). SAHA-sensitive signals corre-
sponding to HDAC1, HDAC2, and MBD3 were visible within 5
min of UV light exposure (Fig. 4, single arrowheads). Interestingly,
multiple SAHA-sensitive targets showed stronger signals in in situ
compared with in vitro labeling experiments (Fig. 4, double arrow-
heads), possibly reflecting superior preservation of certain HDAC
Fig. 3. Alterations in HDACs and HDAC complexes between aggressive and
nonaggressive melanoma lines. (A) ABPP-MudPIT with SAHA-BPyne identiﬁed
lower and higher levels of HDAC6 and CoREST, respectively, in the aggressive
melanomalineMUM2BcomparedwiththelessaggressiveMUM2Cline.P0.01,
forlevelsofproteinsbetweenMUM2BandMUM2Ccells.(B)Westernblottingof
soluble proteomes from melanoma cells conﬁrmed that HDAC6 is more highly
expressed in MUM2C cells (Upper). In contrast, equivalent levels of CoREST were
observed in MUM2B and MUM2C soluble proteomes (Lower). (C) Western blot-
ting analysis of avidin-enriched MUM2B and MUM2C proteomes treated with
SAHA-BPyne revealed stronger CoREST signals in the former samples, indicating
higher levels of CoREST in HDAC complexes from MUM2B cells.
Table 1. Proteins speciﬁcally labeled by SAHA-BPyne in melanoma cell lines
Cell line Protein IPI number
Average spectral counts
SAHA-BPyne
SA HA control
SAHA-
BPyne
SAHA
control
No probe
control
MP
control
MUM2B HDAC1 IPI00013774 18  2 0.5  0.5 1  13  13 6
HDAC2 IPI00289601 21  25  25  25  25
CoREST protein IPI00008531 6.5  0.9 0  00  00  0—
Methyl-CpG binding protein 3 IPI00439194 19  30  00  00  0—
MTA1 IPI00012773 6  1 2.2  0.9 0  01  13
MTA2 IPI00171798 8  21  10  00  06
p66* IPI00103554 2.8  0.9 0  00  00  0—
MUM2C† HDAC1 IPI00013774 20  22  10  01  11 0
HDAC2 IPI00289601 23  2 3.3  0.9 2  21  17
HDAC6 IPI00005711 5  10  00  00  0—
Methyl-CpG binding protein 3 IPI00439194 21  31  10  00  02 1
MTA1 IPI00012773 7.8  0.6 3  03  00  03
MTA2 IPI00171798 10  11  10  00  01 0
p66 IPI00103554 6  1 0.7  0.7 0  00  08
Average spectral counts  SEM for speciﬁcally labeled proteins (as deﬁned in the text). For results from individual runs, see SI Table 2.
*p66 meets the criteria for speciﬁcally labeled proteins only for the MUM2C data set; values for MUM2B are given for comparison.
†One additional protein, translin, was observed as a putatively speciﬁc target in the MUM2C data set; however, spectral counts for this protein in the MUM2B
data set were equivalent between SAHA-BPyne and control runs, suggesting that it is likely a nonspeciﬁc target.
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observedwithothercancerlines(datanotshown).Thesedatashow
that SAHA-BPyne can be used to profile the functional state (and
inhibitor sensitivity) of HDAC complexes directly in living cells.
Discussion
We have described herein the synthesis and biological applica-
tion of an activity-based probe for profiling HDAC complexes in
native proteomes. This probe, SAHA-BPyne, specifically tar-
geted multiple HDACs from both classes I and II, as well as
several HDAC-associated proteins. All of these proteins were
detected in probe-treated proteomes subjected to harsh dena-
turing conditions that would be expected to disrupt noncovalent
protein-protein interactions. We interpret these findings to
indicate that SAHA-BPyne, once bound to HDACs, can interact
with and cross-link to not only HDACs themselves, but also to
those proteins in histone-remodeling complexes that are in close
proximity to HDAC active sites (Fig. 5). This promiscuity can
potentially be explained by examining the crystal structure of
SAHA bound to an HDAC homologue from the thermophilic
bacteria Aquifex aeolicus (15). In this structure, the phenyl ring
of SAHA rests on the lip of the substrate pocket, indicating that
the corresponding benzophenone unit of SAHA-BPyne would
likely reside on the outer rim of the HDAC active site and be
exposed to the local external microenvironment, where interac-
tions could occur with neighboring proteins. Thus, our findings
lead to a model where certain HDAC-associated proteins bind
remarkably close to the HDAC active site, which could poten-
tially explain their strong influence on substrate recognition and
catalysis. Conversely, we hypothesize that those protein constit-
uents of HDAC complexes that were not identified as targets of
SAHA-BPyne in this study, such as RbAp46 and RbAp48 (10),
might be located more distally from HDAC active sites. High-
resolution structural information on HDAC complexes will
likely be required to confirm these ideas.
A comparison of aggressive and nonaggressive melanoma lines
treated with SAHA-BPyne identified targets of this probe that
differed between these cells. Western blotting confirmed these
data, indicating that the differences were, in one case, reflected in
total cellular expression (HDAC6), whereas, in the other case
(CoREST), apparently specific to HDAC complexes themselves.
Differences in HDAC complexes were also observed between
cancer cells of different origins, as melanoma cells displayed
significantly greater signals for MBD3 compared with ovarian
cancer cells. Although the precise functional role that HDACs (and
HDAC-associated proteins) play in cancer remains poorly under-
stood, these data suggest that differences in the composition and
activity of HDAC complexes do exist between cancer cells with
distinct biological properties. Recent studies have shown that the
organization of HDAC complexes is altered by other pathological
processes, such as viral infection (24). HDAC complex formation is
also dynamically regulated by posttranslational events such as
phosphorylation (8). SAHA-BPyne should constitute a powerful
chemical tool for monitoring such changes in HDAC complex
assembly and activity directly in native proteomes or living cells.
From a more technical perspective, our comparative ABPP-
MudPIT results provide further evidence that nonisotopic mass
spectrometry methods, such as spectral counting (25, 26) can be
used to obtain semiquantitative information on the relative
levels of proteins in biological samples. Furthermore, improve-
ments in quantitation could be made by coupling ABPP-
MudPITwithisotopiclabelingmethods(27,28).Finally,wehave
shown that SAHA-BPyne can also be used to profile HDAC
complexes in living cells. These in situ profiling experiments
required exposure of cells to UV irradiation times of as little as
5 min to visualize HDAC targets. Interestingly, multiple SAHA-
sensitive proteins were more strongly labeled in living cells
compared with in vitro proteomic preparations, possibly indicat-
ing that the functional states of certain HDACs/HDAC com-
plexes are compromised by cancer cell homogenization.
There are some potential limitations of this study that merit
discussion.First,weonlyobservedfouroftheelevenhumanclass
I/II HDACs as targets of SAHA-BPyne in the human cancer cell
lines examined. There are several potential reasons why addi-
tional HDAC family members were not detected. First, it is
possible that only a limited number of HDACs were present in
these cell proteomes. A second consideration is that certain
HDACs may have been too low in abundance in the proteomes
for detection by ABPP-MudPIT. For example, due to low
spectral counts and our strict criteria for assigning specific
targets, HDAC3 was not included as target in melanoma cell
proteomes, despite the fact that it was detected in 7 of the 12
samples treated with SAHA-BPyne and in none of the control
proteomes (P  0.01 for MUM2B, P  0.05 for MUM2C).
Additional studies with ovarian cancer lines demonstrated that
HDAC3 is indeed a target of SAHA-BPyne, with an average of
five spectral counts in SAHA-BPyne-treated samples versus no
spectral counts in control proteomes. Future experiments with a
wider range of proteomes that display different patterns of
HDAC expression should clarify the family-wide profiling ca-
pacity of SAHA-BPyne. Additionally, the use of more purified
fractions, such as nuclear preparations, can be analyzed to
amplify the signal of lower abundance targets of SAHA-BPyne
(SI Fig. 7). If this probe proves incapable of labeling certain
HDAC family members, analogs in which the benzophenone
group is repositioned relative to the zinc-chelating hydroxamic
acid can be synthesized to increase photocross-linking efficiency.
Asecondremainingissueisthat,underourcurrentexperimental
protocols, all HDAC and HDAC-associated proteins are identified
as a single collection. These data sets, therefore, do not yet provide
Fig. 4. Proﬁling HDAC complexes in living cancer cells with SAHA-BPyne.
Cultured preparations of MDA-MB-231 cells were treated with 500 nM SAHA-
BPyneprobeinthepresenceorabsenceofexcessSAHA(10M)andirradiated
with UV light for various times. Cells were washed, scraped, and homoge-
nized, followed by click chemistry with a rhodamine-azide tag, SDS/PAGE
analysis, and in-gel ﬂuorescence scanning (ﬂuorescent gel shown in gray-
scale). Multiple SAHA-sensitive targets were detected, including those previ-
ously identiﬁed in in vitro preparations as HDAC1, HDAC2, and MBD3 (single
arrowheads) and those that are more strongly labeled in living cells (double
arrowheads). Labeling of the corresponding in vitro proteomic preparations
of MDA-MB-231 cells is shown for reference.
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HDACs and their associated proteins. This issue could likely be
addressed by using more selective inhibitors of individual HDACs
(instead of the general inhibitor SAHA) as active site competitors.
In this regard, it is also worth considering whether the continued
search for selective inhibitors of individual HDACs might, itself,
benefit from the use of activity-based probes like SAHA-BPyne
that can interrogate HDAC active sites in native proteomes and
living cells. Indeed, others have previously noted the importance of
assessing the selectivity of HDAC inhibitors by screening these
compounds against endogenous HDAC complexes (14).
Finally, our findings have important biomedical implications.
SAHA and other HDAC inhibitors are currently in clinical
development for a range of cancers (7). One potential concern
with these agents is selectivity, especially given that hydroxamic
acids targeting other enzyme classes (e.g., matrix metal-
loproteinases) encountered problems due to unacceptable levels
of toxicity that may have been caused, at least in part, by
‘‘off-target’’ activity (30). Our initial proteomic data indicate
that SAHA, despite its deceptively simple structure, is actually
quite selective for HDACs. We did not observe any specific
targets of SAHA-BPyne in melanoma proteomes other than
HDAC or HDAC-associated proteins. These findings suggest
that the benefits, as well as potential liabilities, that are observed
for SAHA in the clinic will likely be due to the inhibition of
HDACs, rather than other potential protein targets. More
generally, HDACs are only one example of many enzyme classes
that act as part of larger protein complexes in cells (30).
Photoreactive chemical proteomic probes may offer a general
tool to concurrently map the activity state of these enzymes and
the protein interactions that regulate their function.
Methods
Chemical Synthesis. Details of the synthesis and characterization
of SAHA-BPyne are available in SI Text.
Proteome Labeling, Assay Protocol, and Data Analysis. Proteome
samples were diluted in PBS to 1 mg of protein per ml, and
probes were added [100 nM SAHA-BPyne for positive runs;
control runs contained either 10 M SAHA  100 nM SAHA-
BPyne, 100 nM of the MP probe mixture (22), or no probe].
Samples were irradiated, subjected to click chemistry, and
quenched with loading buffer (for gel analysis) or washed,
enriched, and prepared (for MudPIT/gel spot identification/
Western blot analysis), as described (21–23). Further detail can
be found in SI Text. Analysis of SEQUEST search results from
ABPP-MudPIT runs was carried out as described (21).
We acknowledge Heather S. Hoover for assistance with cell culture,
Gabriel M. Simon for designing a program to align SEQUEST data, and
the B.F.C. laboratory for their helpful discussions and suggestions. This
work was supported by the American Cancer Society Grant PF-06-009-
01-CDD(toC.M.S.),NationalInstitutesofHealthGrantCA087660,and
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